Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial-Mesenchymal Barrier.

Nowarski R, Jackson R, Flavell RA.

Cell. 2017 Jan 26;168(3):362-375. doi: 10.1016/j.cell.2016.11.040. Review.

2.

Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.

Nowarski R, Jackson R, Gagliani N, de Zoete MR, Palm NW, Bailis W, Low JS, Harman CC, Graham M, Elinav E, Flavell RA.

Cell. 2015 Dec 3;163(6):1444-56. doi: 10.1016/j.cell.2015.10.072.

3.

APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.

Nowarski R, Prabhu P, Kenig E, Smith Y, Britan-Rosich E, Kotler M.

J Mol Biol. 2014 Jul 29;426(15):2840-53. doi: 10.1016/j.jmb.2014.05.012. Epub 2014 May 21.

4.

Innate immune cells in inflammation and cancer.

Nowarski R, Gagliani N, Huber S, Flavell RA.

Cancer Immunol Res. 2013 Aug;1(2):77-84. doi: 10.1158/2326-6066.CIR-13-0081. Review.

5.

NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion.

Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Philbrick WM, Elinav E, Finlay BB, Flavell RA.

Cell. 2014 Feb 27;156(5):1045-59. doi: 10.1016/j.cell.2014.01.026.

6.

Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms.

Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA.

Nat Rev Cancer. 2013 Nov;13(11):759-71. doi: 10.1038/nrc3611. Review.

PMID:
24154716
7.

APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.

Nowarski R, Kotler M.

Cancer Res. 2013 Jun 15;73(12):3494-8. doi: 10.1158/0008-5472.CAN-13-0728. Epub 2013 Apr 18.

8.

APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair.

Nowarski R, Wilner OI, Cheshin O, Shahar OD, Kenig E, Baraz L, Britan-Rosich E, Nagler A, Harris RS, Goldberg M, Willner I, Kotler M.

Blood. 2012 Jul 12;120(2):366-75. doi: 10.1182/blood-2012-01-402123. Epub 2012 May 29.

9.

Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif.

Britan-Rosich E, Nowarski R, Kotler M.

J Mol Biol. 2011 Jul 29;410(5):1065-76. doi: 10.1016/j.jmb.2011.03.058.

10.

Ubiquitin-fusion as a strategy to modulate protein half-life: A3G antiviral activity revisited.

Cadima-Couto I, Freitas-Vieira A, Nowarski R, Britan-Rosich E, Kotler M, Goncalves J.

Virology. 2009 Oct 25;393(2):286-94. doi: 10.1016/j.virol.2009.07.031. Epub 2009 Aug 29.

11.

An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.

Harjes E, Gross PJ, Chen KM, Lu Y, Shindo K, Nowarski R, Gross JD, Kotler M, Harris RS, Matsuo H.

J Mol Biol. 2009 Jun 26;389(5):819-32. doi: 10.1016/j.jmb.2009.04.031. Epub 2009 Apr 21.

12.

Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase.

Nowarski R, Britan-Rosich E, Shiloach T, Kotler M.

Nat Struct Mol Biol. 2008 Oct;15(10):1059-66. doi: 10.1038/nsmb.1495. Epub 2008 Sep 28.

PMID:
18820687
13.

Spotlighting of cocaine by an autonomous aptamer-based machine.

Shlyahovsky B, Li D, Weizmann Y, Nowarski R, Kotler M, Willner I.

J Am Chem Soc. 2007 Apr 4;129(13):3814-5. Epub 2007 Mar 13. No abstract available.

PMID:
17352479
14.

A virus spotlighted by an autonomous DNA machine.

Weizmann Y, Beissenhirtz MK, Cheglakov Z, Nowarski R, Kotler M, Willner I.

Angew Chem Int Ed Engl. 2006 Nov 13;45(44):7384-8. No abstract available.

PMID:
17036292

Supplemental Content

Loading ...
Support Center